Clinical Trial Technology Editorial
-
PI's CRAACO Model + AI = Rapid Enrollment
6/30/2025
At Dr. David Almeida’s clinical trial site in Erie, PA, he practices the CRAACO model exclusively, relying on the revenue he makes from conducting clinical trials for eye-related diseases. To minimize his costs and speed up trial enrollment, he uses a proprietary AI system that has given him an 85% screen-to-enroll ratio.
-
Breaking Free From The Acronym Soup: Rethinking The Role Of Technology In Clinical Trials
6/30/2025
Ascendis Pharma's Ivanna Rosendal details how clinical systems hinder clinical trial execution and why we should rethink how technology can support our trials.
-
2 Ways To Overcome The Challenge Of Developing Neurological Rare Diseases Drugs
6/16/2025
GRIN Therapeutics CEO Bruce Leuchter, MD, explores how integrating new business models and technological advances will be crucial to developing new treatments for rare neurological disorders.
-
Evolving Neurology And Neuroinflammation Therapies And Trials In 2025
6/5/2025
Could 2025 be the year that advancements in brain health and increased funding for innovative therapies make a difference for neuroinflammation therapies and trials? Immunic CEO Daniel Vitt, Ph.D., discusses.
-
In The Age Of AI, Data Is Still King
5/29/2025
While AI captures attention, data quietly runs the show, says Empactful Ventures Founder Denise Bronner, Ph.D. She explains why proprietary data sets are the foundation of everything AI promises to deliver.
-
What's The Risk Of Letting Researchers Use LLMs?
5/21/2025
Who should be using AI and how? Sage Therapeutics' Jake Alme explores AI use in clinical research, examining its use shifting toward more complex applications and discussing the risk of using it in the public domain.
-
Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind, Part One
5/19/2025
Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part one of this two-part series explores cybersecurity and EHR standards.
-
How AI And Secondary Data Use Are Changing The Way We Do CTAs, Part Two
5/19/2025
Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part two covers the secondary use of study data and AI.
-
Are Sites Even Using AI?: How Sponsors And CROs Can Support Uptake
5/16/2025
How much are clinical research sites using AI? And how can sponsors and CROs effectively support sites in doing so? Consultant Maria P. Ladd explains.
-
5 Ways AI Is Changing Clinical Research — And How To Embrace It
5/15/2025
Discover how AI is transforming clinical trials, learn real tools already in use, and get practical guidance for clinical professionals — especially CRAs and site teams — looking to upskill in an AI-enhanced environment.